150 related articles for article (PubMed ID: 8756084)
21. Dexamethasone-associated toxicity during induction chemotherapy for childhood acute lymphoblastic leukemia is augmented by concurrent use of daunomycin.
Belgaumi AF; Al-Bakrah M; Al-Mahr M; Al-Jefri A; Al-Musa A; Saleh M; Salim MF; Osman M; Osman L; El-Solh H
Cancer; 2003 Jun; 97(11):2898-903. PubMed ID: 12767105
[TBL] [Abstract][Full Text] [Related]
22. Outcome of acute lymphoblastic leukemia in children with AL90 regimen: impact of response to treatment and sex difference on prognostic factors.
Ishii E; Eguchi H; Matsuzaki A; Koga H; Yanai F; Kuroda H; Kawakami K; Ayukawa H; Akiyoshi K; Kamizono J; Tamai Y; Kinukawa N; Okamura J
Med Pediatr Oncol; 2001 Jul; 37(1):10-9. PubMed ID: 11466717
[TBL] [Abstract][Full Text] [Related]
23. [Investigations in the use of mogramostime (GM-CSF) in patients with acute leukemia].
Paśnicki M
Wiad Lek; 1995; 48(1-12):194-7. PubMed ID: 9638239
[No Abstract] [Full Text] [Related]
24. Phase I study of dexamethasone, methotrexate, ifosfamide, L-asparaginase, and etoposide (SMILE) chemotherapy for advanced-stage, relapsed or refractory extranodal natural killer (NK)/T-cell lymphoma and leukemia.
Yamaguchi M; Suzuki R; Kwong YL; Kim WS; Hasegawa Y; Izutsu K; Suzumiya J; Okamura T; Nakamura S; Kawa K; Oshimi K
Cancer Sci; 2008 May; 99(5):1016-20. PubMed ID: 18294294
[TBL] [Abstract][Full Text] [Related]
25. B-lineage acute lymphoblastic leukemia of childhood. An institutional experience.
Rivera-Luna R; Cardenas-Cardos R; Leal-Leal C; Navarro-Alegría I; Meza-Coria C; Gómez-Martínez R; Vega-Vega L
Arch Med Res; 1997; 28(2):233-9. PubMed ID: 9204615
[TBL] [Abstract][Full Text] [Related]
26. [Complete remission achieved by L-asparaginase, vincristine and prednisolone (LVP) therapy in secondary leukemia (M5a type) with an MLL gene rearrangement].
Tomita N; Fujita H; Koharazawa H; Maruta A; Kodama F; Yamamoto T; Kobayashi S; Okubo T
Rinsho Ketsueki; 1997 Feb; 38(2):135-41. PubMed ID: 9059068
[TBL] [Abstract][Full Text] [Related]
27. Growth hormone deficiency after chemotherapy for acute lymphoblastic leukemia in children who have not received cranial radiation.
Haddy TB; Mosher RB; Nunez SB; Reaman GH
Pediatr Blood Cancer; 2006 Feb; 46(2):258-61. PubMed ID: 16369923
[TBL] [Abstract][Full Text] [Related]
28. A dental complication involving Pseudomonas during chemotherapy for acute lymphoblastic leukemia.
Cheatham BD; Henry RJ
J Clin Pediatr Dent; 1994; 18(3):215-7. PubMed ID: 8054308
[TBL] [Abstract][Full Text] [Related]
29. [Multifocal osteonecrosis in children and adolescents after polychemotherapy].
Raab P; Kühl J; Krauspe R
Z Orthop Ihre Grenzgeb; 1997; 135(5):444-50. PubMed ID: 9446438
[TBL] [Abstract][Full Text] [Related]
30. [L-asparaginase therapy against hybrid leukemia: a case report].
Mitani K; Kobayashi Y; Kawamura Y; Usuki K; Yuo A; Ishikawa F; Kitamura T; Ozawa K; Kitamura K; Urabe A
Rinsho Ketsueki; 1988 Sep; 29(9):1442-6. PubMed ID: 3216516
[No Abstract] [Full Text] [Related]
31. [Acute lymphocytic leukemia (L1) preceded by hypercalcemia].
Maruyama H; Kawano K; Uno H; Matsuoka H; Yamashita R; Tamaki N; Ishizaki J; Maeda K; Tsuda K
Rinsho Ketsueki; 1992 Apr; 33(4):514-9. PubMed ID: 1602617
[TBL] [Abstract][Full Text] [Related]
32. Effect of alternate-week versus continuous dexamethasone scheduling on the risk of osteonecrosis in paediatric patients with acute lymphoblastic leukaemia: results from the CCG-1961 randomised cohort trial.
Mattano LA; Devidas M; Nachman JB; Sather HN; Hunger SP; Steinherz PG; Gaynon PS; Seibel NL;
Lancet Oncol; 2012 Sep; 13(9):906-15. PubMed ID: 22901620
[TBL] [Abstract][Full Text] [Related]
33. Thrombotic complications during L-asparaginase treatment for acute lymphocytic leukemia.
Castaman G; Rodeghiero F; Dini E
Haematologica; 1990; 75(6):567-9. PubMed ID: 2098299
[TBL] [Abstract][Full Text] [Related]
34. Intermediate dose methotrexate (IDM) in children with acute lymphocytic leukemia (ALL). An update.
Freeman AI
Sangre (Barc); 1985; 30(6):1007-33. PubMed ID: 3913034
[No Abstract] [Full Text] [Related]
35. Intermediate dose methotrexate and sequential L-asparaginase for treatment of refractory acute lymphocytic leukaemia.
Shetty PA; Kurkure PA; Dasgupta A
Indian J Cancer; 1984; 21(1):45-9. PubMed ID: 6595214
[No Abstract] [Full Text] [Related]
36. Necrosis of the first metacarpal bone in a case of acute lymphatic leukemia in childhood.
Deutinger M; Vollnhofer G
Eur J Pediatr Surg; 1994 Apr; 4(2):116-8. PubMed ID: 8025094
[TBL] [Abstract][Full Text] [Related]
37. [Current status of the treatment of acute lymphocytic leukemia in the adult].
Shi YD; Zhang ZN
Zhonghua Nei Ke Za Zhi; 1989 Aug; 28(8):499-502. PubMed ID: 2689108
[No Abstract] [Full Text] [Related]
38. Moderate dose methotrexate, vincristine, asparaginase, and dexamethasone for treatment of adult acute lymphocytic leukemia.
Esterhay RJ; Wiernik PH; Grove WR; Markus SD; Wesley MN
Blood; 1982 Feb; 59(2):334-45. PubMed ID: 7034815
[TBL] [Abstract][Full Text] [Related]
39. Phase II study of methotrexate, vincristine, pegylated-asparaginase, and dexamethasone (MOpAD) in patients with relapsed/refractory acute lymphoblastic leukemia.
Kadia TM; Kantarjian HM; Thomas DA; O'Brien S; Estrov Z; Ravandi F; Jabbour E; Pemmaraju N; Daver N; Wang X; Jain P; Pierce S; Brandt M; Garcia-Manero G; Cortes J; Borthakur G
Am J Hematol; 2015 Feb; 90(2):120-4. PubMed ID: 25368968
[TBL] [Abstract][Full Text] [Related]
40. Dexamethasone, methotrexate, ifosfamide, L-asparaginase and etoposide (SMILE) chemotherapy for relapsed or refractory adult lymphoblastic lymphoma.
Chang WJ; Ko YH; Kim SJ; Kim WS
Leuk Lymphoma; 2014 Sep; 55(9):2196-8. PubMed ID: 24308435
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]